Skip to main content

Macular Edema clinical trials at UCSD
1 in progress, 0 open to eligible people

  • A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema

    Sorry, accepting new patients by invitation only

    This study will evaluate the efficacy, safety, and pharmacokinetics of faricimab administered at 8-week intervals or as specified in the protocol following treatment initiation, compared with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema (DME). The global enrollment phase has closed, but participants are still being recruited only at sites in China.

    La Jolla, California and other locations

Last updated: